ASML Market Analysis 2026 – Beat, Stock Stalls

ASML Market Analysis

ASML Raised Guidance for the Second Time This Year — Analysts Raised Targets by Hundreds of Dollars, the Stock Didn’t Follow

Key Questions

What did ASML actually report on July 15, and how does it compare to what our last update flagged heading into the print

Worth being precise about the beat, because it wasn’t marginal. ASML had guided Q2 net sales to €8.4-9.0 billion; it delivered €9.3 billion, above the top of its own range. Gross margin was guided to 51-52%; it came in at 54.0%, again above the high end. Here’s what actually drove the beat: management specifically attributed it to higher-than-expected Installed Base Management sales — the recurring service and upgrade revenue tied to machines already in the field, not new-system bookings, which is a meaningfully higher-quality beat than one driven by lumpy new-order timing. Net income reached €2.9 billion. On the back of that, ASML raised full-year 2026 guidance for the second time this year, from the €36-40 billion range set in April to a new €43-45 billion, with full-year gross margin guided to 54-56%. Q3 2026 alone is guided to €11.0-12.0 billion in net sales at a 55-57% margin — implying a meaningfully stronger second half than the already-raised full-year number might suggest on its own.

The MATCH Act was the regulatory overhang we flagged heading into earnings — what’s its actual status now, and did it show up in the numbers

Worth separating where this legislation actually stands from the headline risk it represents. The MATCH Act (Multilateral Alignment of Technology Controls on Hardware), which would tighten controls on ASML’s deep ultraviolet (DUV, a less-advanced lithography technology than extreme ultraviolet, or EUV, but still critical for producing memory and other mainstream chips) equipment sales and servicing to China, passed the House Foreign Affairs Committee by a 44-0 vote on April 22, 2026, and remains on the House calendar awaiting a full floor vote. Its Senate companion was referred to the Banking Committee on April 13 with no markup yet scheduled. So what does this mean in practice: the bill has real bipartisan momentum in the House but has not become law, and ASML’s own guidance already assumes China falls to roughly 20% of 2026 revenue, down from 33% in 2025 — meaning some of the anticipated China slowdown is already priced into the guidance ASML just raised, independent of whether the MATCH Act itself ever passes the Senate.

Analysts raised price targets by hundreds of dollars in the week after earnings — why hasn’t the stock price itself moved to match

This is the genuine tension worth being honest about rather than only celebrating the beat. In the days after the report, Berenberg raised its target to €2,100 from €1,570, Deutsche Bank to €2,150 from €1,800, JPMorgan to $2,400 from $2,200, and Bernstein to $2,623 from $1,971 — several of these increases exceed 20-30% in a single note. Worth stress-testing directly: despite that, ASML shares traded in the $1,740-1,803 range as of July 24, essentially unchanged to modestly lower than the roughly $1,808 level seen just before the report, and still well below the 52-week high near $2,000. The catch: this is not unique to ASML this cycle — the same pattern showed up in TSMC’s own post-earnings stock action — and points to a broader semiconductor-sector derating that individual company results, however strong, have not yet been enough to reverse.

Since our last update, at a glance:

• Q2 net sales: ↑ €9.3B, above the top of guidance
• Q2 gross margin: ↑↑ 54.0%, above the high end of guidance
• Full-year 2026 guidance: ↑↑ raised to €43-45B (from €36-40B) — second raise this year
• New customer confirmation: ↑ Intel Foundry now using ASML lithography machines
• Pricing: ↑ ASML has signaled intent to raise equipment prices
• Analyst targets: ↑↑ multiple firms raised targets 20-30%+ in a single week
• MATCH Act: 🟡 passed House committee 44-0, no Senate action scheduled — unresolved
• Stock price: ➖ essentially flat to lower versus pre-earnings levels, despite all of the above

Key Facts

• Q2 2026 net sales: €9.3 billion, above the guided €8.4-9.0 billion range; gross margin 54.0%, above the guided 51-52%; net income €2.9 billion
• Beat driver: management specifically attributed the outperformance to higher-than-expected Installed Base Management sales (recurring service and field-upgrade revenue), a higher-quality beat than one driven by new-system order timing
• Q3 2026 guidance: net sales €11.0-12.0 billion; gross margin 55-57%
• Full-year 2026 guidance: raised for the second time this year to net sales of €43-45 billion (from €36-40 billion set in April, itself raised from an original €34-39 billion), gross margin 54-56%
• Capacity plans: ASML intends to expand Low-NA EUV and DUV immersion capacity by 30% in 2027, with a further potential 30% expansion in 2028
• New customer confirmation: Intel Foundry is now using ASML’s lithography machines, per company confirmation (July 18) — notable given Intel’s own foundry turnaround narrative
• Pricing signal: commentary following the print indicates ASML intends to raise prices on chipmaking equipment, echoing the same pricing-power dynamic seen at TSMC
• Analyst reaction: price target increases in the week following earnings included Berenberg to €2,100 (from €1,570), Morgan Stanley to €1,930 (from €1,830), Deutsche Bank to €2,150 (from €1,800), Argus to $2,100 (from $1,700), RBC to $2,100 (from $2,000), JPMorgan to $2,400 (from $2,200), and Bernstein to $2,623 (from $1,971); average 12-month analyst target near $2,117, Strong Buy consensus across 44 analysts
• Stock price: traded in the $1,740-1,803 range as of July 24, 2026, versus roughly $1,808 immediately before the report — essentially unchanged despite the beat; 52-week range $683.48-$1,999.96, meaning shares remain well below their own 52-week high
• Market cap: approximately $674.9 billion; normalized P/E near 54.5x
• Dividend: a cash dividend of $2.151 per share was declared, with an ex-date of July 28, 2026
• MATCH Act status: passed the House Foreign Affairs Committee 44-0 on April 22, 2026, and remains on the House calendar for a floor vote; the Senate companion bill was referred to the Banking Committee on April 13 with no markup yet scheduled — the legislation targets DUV lithography sales and servicing to China specifically, beyond the EUV restrictions already in place
• China exposure: ASML’s own guidance already assumes China falls to roughly 20% of 2026 revenue, down from 33% in 2025, independent of whether the MATCH Act itself passes

Five days on from what our last update previewed as an open question, essentially every metric resolved in the constructive operating direction: the beat, the raise, a marquee new customer, and a stated intent to raise prices. The one variable that didn’t resolve cleanly is the stock price itself, which is the detail investors reading only the headline “beat and raise” coverage could easily miss.

The live chart below reflects current ASML share price action in real time.

A Beat This Clean Should Move the Stock — Here’s Why It Hasn’t

The instinctive read on a quarter this strong, paired with the scale of this week’s analyst target increases, is that the stock should already be making new highs. Worth flagging directly: it isn’t, and the gap between fundamental results and share price is itself the more interesting story right now. Part of this is sector-wide rather than ASML-specific — the same disconnect between strong earnings and a muted or negative stock reaction showed up at TSMC the following day, suggesting investors are treating an entire quarter of “beat and raise” semiconductor prints with more skepticism than the numbers alone would justify, likely reflecting broader concerns about AI capital expenditure sustainability that no single company’s results can fully resolve.

The MATCH Act adds a second, ASML-specific layer to that skepticism. Even though the bill has not become law and faces a genuinely uncertain path through the Senate, its 44-0 House committee vote signals real bipartisan appetite to close the DUV servicing loophole that ASML’s China business still partly depends on. So what does this mean in practice: a legislative threat that could still take months or longer to resolve one way or the other is exactly the kind of overhang that depresses a stock’s multiple even when the company’s own guidance already assumes a meaningful China step-down — investors may be pricing a scenario worse than ASML’s own guidance, or simply demanding more clarity before re-rating the stock upward regardless of what this quarter showed.

Current Market Data

ASML trades on Nasdaq under ticker ASML (and on Euronext Amsterdam). As of the most recent trading data, July 24, 2026, shares trade in the $1,740-1,803 range, essentially flat to modestly lower than the roughly $1,808 level seen just before the July 15 earnings report, despite results beating guidance on every major metric and a wave of significant analyst price target increases. The stock remains well below its 52-week high near $1,999.96. The live chart below reflects current price action.

Sources

• ASML — Q2 2026 Financial Results (Official Press Release)
• Yahoo Finance — ASML Reports €9.3 Billion Total Net Sales and €2.9 Billion Net Income in Q2 2026
• StockAnalysis.com — ASML Holding (ASML) Stock Overview and Guidance History
• Morningstar — ASML Stock Price Quote
• CNN Markets — ASML Stock Quote, Price Targets and Forecast
• Senate Foreign Relations Committee — Risch, Ricketts, Kim Introduce MATCH Act
• Model Diplomat — MATCH Act’s 44-0 Committee Vote on Chip Exports

This quarter’s semiconductor equipment news connects directly to TSMC, ASML’s largest customer, which reported its own beat-and-raise quarter the day after ASML with a strikingly similar muted stock reaction, and to Nvidia and AMD, both of whom depend on the same advanced-node capacity ASML’s lithography tools make possible.

About MP24 Analyst X

Published by MP24 Analyst X. Read our Editorial and Content Policy to understand our compliance and brand publishing standards.

MP24 Analyst X is the public-facing pseudonym used for MatrixPro24’s research and editorial work across macroeconomics, commodities, cryptocurrencies, equities, and global financial markets. MatrixPro24 research emphasizes evidence, transparency, and structured reasoning over speculation and market hype.

Disclaimer

This analysis is for informational and educational purposes only and does not constitute personalized financial or investment advice or a MatrixPro24 recommendation to buy, sell, or hold a financial instrument. This editorial/methodology review was completed on August 13, 2026. Market-price figures and dated market reactions remain tied to the observation dates stated in the article; use the live TradingView chart for current market pricing. Past performance is not indicative of future results. Conduct your own independent research before making financial decisions.